Medium materiality5/10
Jefferies Starts Haemonetics at Buy
Why it may matterVerify against the original reporting
The Buy initiation and target imply meaningful upside, though this is an analyst opinion rather than a company-specific catalyst.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies initiated coverage of Haemonetics with a Buy rating and a $150 target, versus a posted price of $122.71.
- Jefferies starts HAE at Buy with a $150 target.
Key facts
- 01
Target: $150
- 02
Posted price: $122.71
- 03
Analyst firm: Jefferies
- 04
Analyst: Young Li
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.